COMPLETE SOLUTION 2026/2027 | Head-to-Toe Examination
| Clinical Integration | A+ Graded - Pass Guaranteed
Section 1: Health History (8 Questions)
Q1: When beginning a comprehensive health history with Tina Jones, which opening
question is MOST appropriate to establish rapport and gather initial information?
A. "I need to ask you a long list of questions about your health. Is that okay?"
B. "What would you like me to call you? And what brings you to the clinic today?"
[CORRECT]
C. "Let's start with your medical history. Do you have any chronic conditions?"
D. "How are you feeling today?"
Correct Answer: B
Rationale: Per Jarvis (2024) and AACN Essentials for Professional Nursing Education
(2021), establishing rapport begins with person-centered communication—asking
preferred names and open-ended chief complaint questions. Option B demonstrates
therapeutic communication by respecting patient identity (asking preferred name) and
using an open-ended question to elicit the patient's perspective on their health
concerns. Option A frames the interaction as burdensome. Option C jumps to
closed-ended medical data collection without rapport building. Option D is too broad
and may elicit only a social response ("fine") rather than health concerns. The
,open-ended approach yields richer data and establishes the nurse-patient partnership
essential for comprehensive assessment.
Q2: During the health history, Tina Jones mentions she has asthma, diabetes Type 2,
and hypertension. Which question BEST demonstrates clinical reasoning to explore
connections between these conditions?
A. "Which condition bothers you the most?"
B. "How do you manage each of these conditions separately?"
C. "Have you noticed if your blood sugar affects your breathing, or if stress impacts all
three conditions?" [CORRECT]
D. "When were each of these diagnosed?"
Correct Answer: C
Rationale: Clinical integration requires identifying pathophysiological and behavioral
interconnections (QSEN Competency: Integrated Processes of Care). Diabetes,
hypertension, and asthma share inflammatory pathways, stress responses, and
medication interactions. Option C explores these connections—hyperglycemia can
affect immune response and asthma control; stress triggers cortisol release affecting
glucose and blood pressure while potentially triggering bronchospasm. Option A
prioritizes subjectively without exploring relationships. Option B assumes separate
management rather than integrated care. Option D collects historical data without
exploring current clinical interactions. Understanding these connections informs
comprehensive care planning for patients with multiple comorbidities.
,Q3: [Select-All-That-Apply] Which information should be collected during the medication
history portion of a comprehensive assessment for a patient with diabetes,
hypertension, and asthma?
A. Prescription medications and dosages
B. Over-the-counter medications and supplements
C. Herbal remedies and traditional medicines
D. Medication adherence patterns and barriers
E. Allergies and adverse reactions to medications
F. Pharmacy location and insurance coverage [CORRECT: A, B, C, D, E]
Correct Answer: A, B, C, D, E
Rationale: Per Bates' Guide to Physical Examination and History Taking (13th ed.) and
the Joint Commission National Patient Safety Goals, comprehensive medication
reconciliation includes: prescription medications (A), OTC products including
supplements that may interact with antihypertensives or affect glucose (B),
herbal/traditional medicines with potential drug-herb interactions (C), adherence
assessment critical for chronic disease management (D), and allergy history essential
for preventing adverse reactions (E). Option F (pharmacy/insurance) is administrative
data not directly relevant to clinical medication safety assessment. For Tina Jones with
polypharmacy (likely metformin, antihypertensive, and albuterol), this comprehensive
approach prevents missed interactions and identifies adherence barriers affecting
disease control.
, Q4: Tina reports using her albuterol inhaler "whenever I feel wheezy, probably 4-5 times
a week, sometimes more." What is the clinical significance and appropriate follow-up
question?
A. This indicates good asthma control; ask about exercise tolerance
B. This indicates poor asthma control; ask about nighttime symptoms and activity
limitation [CORRECT]
C. This indicates medication overuse; ask about anxiety symptoms
D. This indicates appropriate rescue inhaler use; ask about technique only
Correct Answer: B
Rationale: Per NHLBI Asthma Guidelines (2020 Focused Updates) and Global Initiative
for Asthma (GINA) 2024, using a short-acting beta-agonist (SABA) more than 2 days per
week indicates poor asthma control and increased risk of exacerbation. Option B
correctly identifies this as poor control requiring assessment of nighttime awakening
(indicator of severe asthma) and activity limitation (functional impact). Option A
incorrectly interprets frequent rescue use as control. Option C misattributes symptoms
to anxiety without assessing true asthma status. Option D misses the clinical
significance of frequency. Follow-up should include assessing need for controller
medication adjustment and evaluating for environmental triggers given her diabetes and
hypertension (systemic inflammation connections).
Q5: [Ordered-Response] Place the following components of the health history in the
CORRECT sequence for a comprehensive assessment:
1. Family history
2. Chief complaint